Colin J. Rog MD , Riom Kwakman MD , Charlotte van Schooten MD , Chloe Hanson MD , Elizabeth J. Olecki MD , Richard A. Erali MD , Joy Sarkar MD , Erek Nelson MD , Matthew G.K. Benesch MD, PhD , Shalana O'Brien MD , Gary Mann MD , Joseph Skitzki MD , Mohamed Alassas MD , Evan S. Ong MD
{"title":"细胞还原及腹腔内高温化疗患者吻合口瘘的不典型表现及延迟时间","authors":"Colin J. Rog MD , Riom Kwakman MD , Charlotte van Schooten MD , Chloe Hanson MD , Elizabeth J. Olecki MD , Richard A. Erali MD , Joy Sarkar MD , Erek Nelson MD , Matthew G.K. Benesch MD, PhD , Shalana O'Brien MD , Gary Mann MD , Joseph Skitzki MD , Mohamed Alassas MD , Evan S. Ong MD","doi":"10.1016/j.jss.2025.09.037","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Anastomotic leak (AL) can be a disproportionately devastating complication following cytoreductive surgery (CRS)/hyperthermic intraperitoneal chemotherapy (HIPEC) due to its effect on both perioperative and oncologic outcomes. Anecdotally, patients who underwent CRS/HIPEC present in an atypically fashion compared to those who undergo non-CRS/HIPEC gastrointestinal surgery, but this has never been rigorously studied.</div></div><div><h3>Methods</h3><div>The records for all consecutive patients who underwent CRS/HIPEC with curative intent from prospectively maintained databases at two high-volume centers were retrospectively reviewed. Those who experienced AL were identified and dichotomized into early (<POD10) and late (≥ POD 10) AL. Groups were analyzed using chi-squared, Fisher exact tests, and analysis of variance for categorical data and Mann–Whitney U or Kruskall–Wallis for continuous data.</div></div><div><h3>Results</h3><div>On median postoperative day (POD) 15, 6.1% of patients experienced AL . Demographics, disease histology, risk factors for AL, receipt of neoadjuvant therapy, and extent of surgery were well-balanced. A higher proportion of small bowel anastomoses leaked in <POD10, whereas a higher proportion of ileocolonic and colorectal anastomoses leaked ≥ POD10. Patients in the late group were also significantly less likely to present with fever, tachycardia, and hypotension compared to patients in the early group, and patients in both cohorts were unlikely to present with peritonitis or leukocytosis.</div></div><div><h3>Conclusions</h3><div>Patients who experience AL after CRS/HIPEC often present in an atypical manner compared to those who undergo non-CRS/HIPEC gastrointestinal surgery. These findings are important to any practitioner who encounters CRS/HIPEC patients given that early recognition of AL is crucial to mitigating subsequent sequelae that can negatively impact both short-term perioperative and long-term oncologic outcomes in this uniquely challenging population.</div></div>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"315 ","pages":"Pages 331-337"},"PeriodicalIF":1.7000,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Atypical Presentation and Delayed Timing of Anastomotic Leak in Patients Who Undergo Cytoreducation and Hyperthermic Intraperitoneal Chemotherapy\",\"authors\":\"Colin J. Rog MD , Riom Kwakman MD , Charlotte van Schooten MD , Chloe Hanson MD , Elizabeth J. Olecki MD , Richard A. Erali MD , Joy Sarkar MD , Erek Nelson MD , Matthew G.K. Benesch MD, PhD , Shalana O'Brien MD , Gary Mann MD , Joseph Skitzki MD , Mohamed Alassas MD , Evan S. Ong MD\",\"doi\":\"10.1016/j.jss.2025.09.037\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>Anastomotic leak (AL) can be a disproportionately devastating complication following cytoreductive surgery (CRS)/hyperthermic intraperitoneal chemotherapy (HIPEC) due to its effect on both perioperative and oncologic outcomes. Anecdotally, patients who underwent CRS/HIPEC present in an atypically fashion compared to those who undergo non-CRS/HIPEC gastrointestinal surgery, but this has never been rigorously studied.</div></div><div><h3>Methods</h3><div>The records for all consecutive patients who underwent CRS/HIPEC with curative intent from prospectively maintained databases at two high-volume centers were retrospectively reviewed. Those who experienced AL were identified and dichotomized into early (<POD10) and late (≥ POD 10) AL. Groups were analyzed using chi-squared, Fisher exact tests, and analysis of variance for categorical data and Mann–Whitney U or Kruskall–Wallis for continuous data.</div></div><div><h3>Results</h3><div>On median postoperative day (POD) 15, 6.1% of patients experienced AL . Demographics, disease histology, risk factors for AL, receipt of neoadjuvant therapy, and extent of surgery were well-balanced. A higher proportion of small bowel anastomoses leaked in <POD10, whereas a higher proportion of ileocolonic and colorectal anastomoses leaked ≥ POD10. Patients in the late group were also significantly less likely to present with fever, tachycardia, and hypotension compared to patients in the early group, and patients in both cohorts were unlikely to present with peritonitis or leukocytosis.</div></div><div><h3>Conclusions</h3><div>Patients who experience AL after CRS/HIPEC often present in an atypical manner compared to those who undergo non-CRS/HIPEC gastrointestinal surgery. These findings are important to any practitioner who encounters CRS/HIPEC patients given that early recognition of AL is crucial to mitigating subsequent sequelae that can negatively impact both short-term perioperative and long-term oncologic outcomes in this uniquely challenging population.</div></div>\",\"PeriodicalId\":17030,\"journal\":{\"name\":\"Journal of Surgical Research\",\"volume\":\"315 \",\"pages\":\"Pages 331-337\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-10-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Surgical Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0022480425005918\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Surgical Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0022480425005918","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
The Atypical Presentation and Delayed Timing of Anastomotic Leak in Patients Who Undergo Cytoreducation and Hyperthermic Intraperitoneal Chemotherapy
Introduction
Anastomotic leak (AL) can be a disproportionately devastating complication following cytoreductive surgery (CRS)/hyperthermic intraperitoneal chemotherapy (HIPEC) due to its effect on both perioperative and oncologic outcomes. Anecdotally, patients who underwent CRS/HIPEC present in an atypically fashion compared to those who undergo non-CRS/HIPEC gastrointestinal surgery, but this has never been rigorously studied.
Methods
The records for all consecutive patients who underwent CRS/HIPEC with curative intent from prospectively maintained databases at two high-volume centers were retrospectively reviewed. Those who experienced AL were identified and dichotomized into early (<POD10) and late (≥ POD 10) AL. Groups were analyzed using chi-squared, Fisher exact tests, and analysis of variance for categorical data and Mann–Whitney U or Kruskall–Wallis for continuous data.
Results
On median postoperative day (POD) 15, 6.1% of patients experienced AL . Demographics, disease histology, risk factors for AL, receipt of neoadjuvant therapy, and extent of surgery were well-balanced. A higher proportion of small bowel anastomoses leaked in <POD10, whereas a higher proportion of ileocolonic and colorectal anastomoses leaked ≥ POD10. Patients in the late group were also significantly less likely to present with fever, tachycardia, and hypotension compared to patients in the early group, and patients in both cohorts were unlikely to present with peritonitis or leukocytosis.
Conclusions
Patients who experience AL after CRS/HIPEC often present in an atypical manner compared to those who undergo non-CRS/HIPEC gastrointestinal surgery. These findings are important to any practitioner who encounters CRS/HIPEC patients given that early recognition of AL is crucial to mitigating subsequent sequelae that can negatively impact both short-term perioperative and long-term oncologic outcomes in this uniquely challenging population.
期刊介绍:
The Journal of Surgical Research: Clinical and Laboratory Investigation publishes original articles concerned with clinical and laboratory investigations relevant to surgical practice and teaching. The journal emphasizes reports of clinical investigations or fundamental research bearing directly on surgical management that will be of general interest to a broad range of surgeons and surgical researchers. The articles presented need not have been the products of surgeons or of surgical laboratories.
The Journal of Surgical Research also features review articles and special articles relating to educational, research, or social issues of interest to the academic surgical community.